NovMetaPharma Co., Ltd. (XKON:229500)
4,890.00
+390.00 (8.67%)
At close: Sep 3, 2026
| Market Cap | 64.02B -64.3% |
| Revenue (ttm) | 1.30B +21.4% |
| Net Income | 408.03M |
| EPS | 120.00 |
| Shares Out | 12.84M |
| PE Ratio | 41.54 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 655 |
| Open | 4,600.00 |
| Previous Close | 4,500.00 |
| Day's Range | 4,600.00 - 4,900.00 |
| 52-Week Range | 3,905.00 - 16,800.00 |
| Beta | 0.13 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |